Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1970 1
1974 1
1976 2
1977 4
1978 1
1979 1
1980 1
1981 1
1983 2
1984 2
1985 5
1986 2
1987 4
1988 4
1989 3
1990 2
1991 1
1992 10
1993 1
1994 4
1995 8
1996 4
1997 6
1998 7
1999 7
2000 7
2001 14
2002 8
2003 7
2004 11
2005 8
2006 7
2007 18
2008 11
2009 15
2010 13
2011 21
2012 19
2013 19
2014 12
2015 14
2016 17
2017 15
2018 18
2019 24
2020 28
2021 19
2022 23
2023 18
2024 18
2025 25
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

449 results

Results by year

Filters applied: . Clear all
Page 1
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS; Society for Immunotherapy of Cancer Toxicity Management Working Group. Puzanov I, et al. J Immunother Cancer. 2017 Nov 21;5(1):95. doi: 10.1186/s40425-017-0300-z. J Immunother Cancer. 2017. PMID: 29162153 Free PMC article.
Effectiveness of neural mobilisation for the treatment of nerve-related cervicobrachial pain: a systematic review with subgroup meta-analysis.
Lascurain-Aguirrebeña I, Dominguez L, Villanueva-Ruiz I, Ballesteros J, Rueda-Etxeberria M, Rueda JR, Casado-Zumeta X, Araolaza-Arrieta M, Arbillaga-Etxarri A, Tampin B. Lascurain-Aguirrebeña I, et al. Among authors: ballesteros j. Pain. 2024 Mar 1;165(3):537-549. doi: 10.1097/j.pain.0000000000003071. Epub 2023 Oct 23. Pain. 2024. PMID: 37870223
Common errors in statistics and methods.
Flom P, Harron K, Ballesteros J, Kalinda C, Koutoumanou E, Miles J, Nevitt SJ, Rohloff P. Flom P, et al. Among authors: ballesteros j. BMJ Paediatr Open. 2024 Sep 15;8(1):e002755. doi: 10.1136/bmjpo-2024-002755. BMJ Paediatr Open. 2024. PMID: 39284617 Free PMC article. Review.
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry.
Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, Gómez-Huelgas R, Ramos-Rincón JM, Rubio-Rivas M, Corrales-González MÁ, Fernández-Madera-Martínez MR, Beato-Pérez JL, Arnalich-Fernández F, Gállego-Lezaun C, Pérez-Martínez P, Molinos-Castro S, Tung-Chen Y, Madrazo M, Méndez-Bailón M, Monge-Monge D, García-García GM, García-Fenoll R, Gilabert N, Fuerte-Martínez R, Contreras-Sánchez M, Rhyman N, Peris-García J, Lumbreras-Bermejo C; SEMI-COVID-19 Network. Casas-Rojo JM, et al. Sci Rep. 2023 Oct 18;13(1):17731. doi: 10.1038/s41598-023-42735-5. Sci Rep. 2023. PMID: 37853011 Free PMC article.
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.
Oblitas CM, Demelo-Rodríguez P, Barrera-López L, Galeano-Valle F, Rubio-Rivas M, Luque Del Pino J, Giner Galvañ V, Paredes-Ruíz D, Fernández-Madera Martínez R, Gericó Aseguinolaza M, Gómez-Huelgas R, Fernández FA, Torres Peña JD, Martín González JI, Méndez-Bailón M, Monge Monge D, Freire Castro SJ, Pastor Valverde C, Rodilla-Sala E, Guzmán García M, Rivas-Carmenado M, Gallo CM, Perea Ribis MA, Casas-Rojo JM, Millán Núñez-Cortés J; SEMICOVID-19 Network. Oblitas CM, et al. Sci Rep. 2025 Mar 5;15(1):7722. doi: 10.1038/s41598-025-90278-8. Sci Rep. 2025. PMID: 40044746 Free PMC article.
Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size.
De La Torre Tarazona E, Moraga E, Vaquer R, Sánchez-Palomino S, de Lazzari E, Luna L, Vicens-Artés S, García Fraile LJ, Peraire J, Garcia-Gasalla M, Balsalobre L, Guillén Martínez S, López Cortés LF, Jarrín I, Serrano-Villar S, Alcamí J, Moreno S; CoRIS Cohort. De La Torre Tarazona E, et al. Sci Rep. 2025 Jul 13;15(1):25306. doi: 10.1038/s41598-025-09474-1. Sci Rep. 2025. PMID: 40653494 Free PMC article.
449 results